title: Aspirin use and melanoma risk: a review of the literature.
abstract: In view of the increasing incidence of melanoma, it is critical to find effective preventive approaches. Contradictory evidence has been reported with regard to the possible association of aspirin use and the risk of melanoma. We review these studies and seek to elucidate the mechanism by which aspirin may produce a chemoprotective effect against melanoma.
authors.affiliation: David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. Electronic address: sfamenini@mednet.ucla.edu.
authors.forename: Shannon
authors.initials: S
authors.lastname: Famenini
authors.affiliation: Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
authors.forename: Lorraine C
authors.initials: LC
authors.lastname: Young
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D006801:Humans; D008545:Melanoma / Q000517:prevention & control*; D012878:Skin Neoplasms / Q000517:prevention & control*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016588:Anticarcinogenic Agents; D001241:Aspirin
keywords: CI; HR; NSAID; aspirin; confidence interval; hazard ratio; melanoma; nonsteroidal anti-inflammatory drugs